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Abstract: Au- and iron-based magnetic nanoparticles (NPs) are promising NPs for biomedical
applications due to their unique properties. The combination of a gold coating over a magnetic core
puts together the benefits from adding the magnetic properties to the robust chemistry provided
by the thiol functionalization of gold. Here, the use of Au-coated magnetic NPs for molecular
detection of a single methylation in DNA aptamer is described. Binding of α-thrombin to two
aptamers conjugated to these NPs causes aggregation, a phenomenon that can be observed by UV,
DLS and MRI. These techniques discriminate a single methylation in one of the aptamers, preventing
aggregation due to the inability of α-thrombin to recognize it. A parallel study with gold and
ferromagnetic NPs is detailed, concluding that the Au coating of FexOy NP does not affect their
performance and that they are suitable as complex biosensors. These results prove the high detection
potency of Au-coated SPIONs for biomedical applications especially for DNA repair detection.
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1. Introduction
In the last decades, a large effort has been made in the development of novel synthetic methods
and functionalization of nanoparticles with biologically relevant biomolecules. This effort has led to
a large number of biomedical applications such as novel diagnostic tools, delivery of drugs especially
the ones that have toxic side effects, new materials for tissue engineering and new tools for molecular
biology [1–3].
In particular, the controlled assembly of gold nanoparticles (AuNPs) has been a subject of
great interest in the new field of nanobiotechnology [4–12]. This interest comes form the unique
physical properties such as their localized surface plasmon resonance (LSPR) [13] and their efficient
interaction with molecules with a free thiol group. In this way a large interest for functionalized
AuNPs as potential building blocks to build nanoscale photonic and electronic devices has been
developed [14–22]. After the description of the first DNA sensor by Mirkin et al. [23], the development
of AuNPs-based colorimetric biosensors has been applied in the detection of most of the biomedical
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relevant molecular targets such as nucleic acids [17,24], proteins [15,25,26], saccharides [27], ions
and small molecules [28,29] and even intact cells [30,31]. This technique takes advantage of the
color changes during AuNP aggregation or redispersion events [4,5,10] and have a great potential
to developed new analytical methods in the fields of analysis of environmental contaminants [28,29],
clinical diagnosis [30,31], and drug discovery [32] among others.
Besides, super paramagnetic iron oxide nanoparticles (SPIONs) possess different interesting
features for nanomedicine. SPIONs are well known as innovative agents in diagnostics, due to their
advantages as Magnetic Resonance Imaging (MRI) contrast agents [33,34]. In comparison with the
traditional contrast agents, SPIONs are less toxic, and have a strong enhancement of proton relaxation
together with a low detection limit [35,36]. Furthermore, SPIONs have several other applications in
biomedicine, especially for delivery purposes, due to their reduced size, the ability to be transported
in biological systems [37–41] and the potential use for therapy by magnetic heating [42–44].
Gold and iron-based magnetic nanoparticles (AuSPIONs) have a prominent potential in
biomedical applications due to their unique properties. The gold coating of a magnetic core combines
the benefits from both nanoparticles, adding the magnetic properties to the robust chemistry provided
by the thiol functionalization of the gold coating. For this reason, there is an increasing interest on the
synthesis and applications of this type of gold-coated nanoparticles [39,40,45–49].
In this work, we describe the use of gold coated magnetic nanoparticles as molecular detection
systems, through their functionalization with DNA aptamers that are recognized by the protein
α-thrombin. For this purpose, we conjugated the α-thrombin binding aptamers 1 and 2 (TBA1
and TBA2), and a methylated version of TBA1 (O6-MedG-TBA1) (Table 1) to gold-coated iron–oxide
nanoparticles, to iron-oxide nanoparticles and gold nanoparticles, in order to assess the advantages
of each type of NPs. The TBA1 and TBA2 sequences bind cooperatively to specific epitopes of
α-thrombin, forming a “molecular sandwich” complex [50]. TBA1 [51] is a 15 mer nucleotide and
TBA2 is 29 mer [50].
Table 1. Oligonucleotide sequences of the three α-thrombin binding aptamers.
Name Sequence
TBA1 HS-5’-T15GGTTGGTGTGGTTGG-3’
TBA2 HS-5’-T5AGTCCGTGGTAGGGCAGGTTGGGGTGACT-3’
O6-MeG-TBA1 HS-5’-T15GGTTGMeGTGTGGTTGG-3’
The mixture of TBA1 and TBA2 conjugated nanoparticles should form a tridimensional network
in presence of α-thrombin [41], as represented in Scheme 1. This interaction can be detected in a
straightforward manner using three types of techniques: Ultraviolet spectroscopy (UV), Dynamic
Light Scattering (DLS) and Magnetic resonance imaging (MRI). AuSPIONs and AuNPs have a
maximum of absorbance due to their surface plasmon resonance at 520 nm that shifts to higher
wavelengths when aggregation occurs and this change is easily detected by UV-spectroscopy.
Aggregation of the three types of nanoparticles can be detected by DLS, measuring the main
hydrodynamic diameter (HD) of the nanoparticles resulting in a huge increase when α-thrombin
is added to the mixture of nanoparticles carrying the TBAs. Finally, SPIONs and AuSPIONs allow
the detection of the complex between α-thrombin and thenanoparticles by means of MRI, because
they are contrast agents for image enhancement.
Furthermore, we also explored the discrimination capacity of the AuSPION nanoparticles to
detect a single methylation in the DNA aptamer, upon destabilizing the quadruplex structure of TBA1
by the incorporation of a methyl-G in one of its tetrads. In this case, the mixture is not expected to
form a tridimensional network because α-thrombin is not able to recognize this modified version
of the aptamer [52,53]. Moreover, this inability to form the network allowed us to use this set of
nanoparticles as a detection probe for a single methylation. This system can be further developed for
the detection of the activity of DNA repair proteins, which have alkylated guanines as substrate.
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Scheme 1. Representation of the TBA-conjugated nanoparticles and the tridimensional network 
formation in presence of α-thrombin for the unmodified TBAs. TBA1 and TBA2 are represented folded in 
their chair like structure in dark blue and in green clusters respectively α-thrombin is represented in 
light purple cluster. 
2. Results and Discussion 
2.1. Preparation of Gold Superparamagnetic Iron Oxide Nanoparticles (AuSPION) 
The preparation of the gold-coated nanoparticles was performed following a process consisting 
of two main steps, the precipitation of the ferromagnetic seeds followed by their coating with gold 
acetate [45,46]. This synthetic route allows the formation of homogeneous deposition of Au through 
a seed mediated process [45,46]. The precipitation of ferromagnetic seeds was obtained in good 
yield, and the resulting nanoparticle cores were characterized by TEM. TEM images (Figure 1a) 
show homogeneity in size and shape of the ferromagnetic core, which is an indispensable condition 
to achieve the final AuSPION. Then, gold acetate (source of Au3+) is adsorbed and reduced directly 
onto the NP surface to add the gold shell to the SPIONs. The purified gold-coated magnetic 
nanoparticles were obtained with high yield of coating and analyzed by transmission electron 
microscopy (TEM) (Figure 1b), showing an increase of around 1.6 nm in the core diameter, which 
confirms that the covering was obtained successfully. Finally, an energy dispersive X-ray analysis 
via scanning transmission electron microscopy (STEM–EDX) on discrete particles shows the 
co-presence of Au and Fe (ESI, Figure S1) along with the smooth and nearly spherical morphology [48]. 
 
Figure 1. TEM images of the gold-coated magnetic nanoparticles, AuSPION. Images and particle size 
distribution of the ferromagnetic cores (a) and gold-coated SPION (b). 
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2.2. Conjugation of the AuNPs, AuSPIONs and SPIONs with TBA1, TBA2 and O6-MeG-TBA1
TBA1 and TBA2, that bind to opposite sites of α-thrombin, and O6-MeG-TBA1 were conjugated
separately and successfully to the three types of nanoparticles selected in this work.
The conjugation of TBAs to AuNPs (commercially available) and AuSPIONs was done by
incubation of NPs with thiolated-oligonucleotides followed by slow salt aging as described [54].
The superparamagnetic nanoparticles were prepared as reported [55,56] and coated with
dimercaptosuccinic acid (DMSA) [57]. Two type of linkers (maleimide [58] and disulfide [59],
Figure 2) were used to functionalize these nanoparticles with TBAs. In order to introduce these
functionalities, the carboxylate groups of DMSA were activated using EDC/NHS and then reacted
with the amino groups of the corresponding linkers bearing a maleimide or disulfide moiety. The
synthesis and NMR spectra of the linkers isolated as hydrochlorides are described in detail in the
supplementary material section. In order to generate the free amino groups, 1 equivalent of sodium
bicarbonate was used. The stability of the maleimido linker to these conditions was analyzed
by 1H-NMR showing no significant changes in the spectrum (ESI, Figure S2). Subsequently, the
resulting SPIONs were reacted with the corresponding thiolated–oligonucleotides. The degree of
functionalization of SPIONs with TBAs was independent of the type of linker and they were further
used indistinguishably.
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Figure 2. Schematic representation of the functionalization of SPIONs nanoparticles with TBAs (in 
green), using the two type of linkers maleimide (left) and disulfide (right). 
The functionalization of all the nanoparticles was confirmed by the quantification of the 
decrease in the concentration of the oligonucleotide present in the solution, before and after 
conjugation (data not shown). All nanoparticles were stable after centrifugation and resuspension 
with aqueous buffers. 
2.3. UV Study of the Complex Formation between α-Thrombin and AuNPs or AuSPIONs Functionalized with TBAs 
The behavior of TBAs functionalized nanoparticles when incubated with α-thrombin was 
monitored by means of UV-spectroscopy observing the red-shift broadness of the surface Plasmon 
band [4,23]. 
Binding interaction of the modified AuNPs–TBAs and AuSPIONs–TBAs with α-thrombin was 
carried out in phosphate buffer with additional K+ at 25 °C. As expected, the UV spectrum for TBA1 
and TBA2 anchored to AuNPs or AuSPIONs showed a maximum of absorption at 520 nm before 
incubation with α-thrombin (Figure 3). This maximum was displaced to higher wavelengths in a 
Figure 2. Schematic representation of the functionalization of SPIONs nanoparticles with TBAs
(in green), using the two type of linkers maleimide (left) and disulfide (right).
The functionalization of all the nanoparticles was confirmed by the q antification of the decrease
in the concentration of the ligonucleotide present in the solution, before nd after conjugatio (data
not shown). All nanoparticles were stable after centrifugation and resuspension with aqueous buffers.
2.3. UV Study of the Compl ormation between α-Thrombin and AuNPs or AuSPIONs Functionalized
with TBAs
The behavior of TBAs functionalized nanoparticles when incubated with α-thrombin was
monitored by means of UV-spectroscopy observing the red-shift broadness of the surface Plasmon
band [4,23].
Binding interaction of the modified AuNPs–TBAs and AuSPIONs–TBAs with α-thrombin was
carried out in phosphate buffer with additional K+ at 25 ˝C. As expected, the UV spectrum for TBA1
and TBA2 anchored to AuNPs or AuSPIONs showed a maximum of absorption at 520 nm before
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incubation with α-thrombin (Figure 3). This maximum was displaced to higher wavelengths in a
continuous way when α-thrombin was added, until reaching stabilization (30 nm). The UV spectra
of these titrations are shown in Figure S3 (ESI).
These results confirmed that α-thrombin was interacting with both TBA1 and TBA2, creating a
NP network formed by the binding of thrombin to both TBA1 and TBA2 sequences. In addition, the
formation of this network of interactions between α-thrombin and TBAs is not affected by the nature
of the nanoparticles, as both AuNPs and AuSPIONs showed the same response with a detection limit
in the 125 to 250 picomolar range.
In contrast, the interaction between α-thrombin and the mixture of O6-MeG-TBA1 and TBA2
anchored to the two types of nanoparticles (AuNPs or AuSPIONs) was evidently smaller. As it
can be seen in Figure 3b,d, at equal concentrations of α-thrombin the maximum of absorption was
not changed in AuNPs (Figure 3b) or slightly displaced in Au SPIONs (Figure 3d). This small
difference in the displacement rate observed in Au SPIONs (less than 10 nm) can be explained by
the only interaction of AuNPs–TBA2 or AuSPIONs–TBA2 with α-thrombin. These observations
proved that α-thrombin was not able to form the network with the same performance as in the case
of the unmodified TBAs, and that its KD is much higher when one guanine in the central tetrad of
the TBA sequence is modified with a methyl group in the O6 position. This simple modification
prevents the formation of its quadruplex structure, and for this reason, it cannot be recognized by
α-thrombin. Moreover, when we forced the concentration ofα-thrombin versus TBAs (molar ratio 4:1),
we could observe a small displacement of the maximum in the UV spectrum of the mixture containing
the methylG-TBA1 conjugated with both types of NPs. This effect could be due to the formation
of small clusters, even if in a reduced way if compared to the non-methylated mixture of TBAs
(10 nm for AuSPIONs and 15 nm for AuNPs). As the protein itself is able to recognize the sequence
of methylated TBA and force it to fold in its quadruplex structure suitable for the binding [52], we
presume that the methylated sequence is also recognized as a result of the excess of protein in the
mixture. It is interesting to note that α-thrombin attempts to fold it and this may result in some
degree of binding.
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Figure 3. UV–Visible spectra of the complex formation between TBAs and α-thrombin at a molar
ratio of (1:1). The curves represent the mixture of NPs–TBAs in the absence (dashed lines) and in
the presence (orange continuous lines) of the α-thrombin. Blue represents unmodified TBAs and
green, methylated TBAs: (a,b) display spectra recorded for AuNPs; and (c,d) display spectra recorded
for AuSPIONs.
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UV seems a proper and simple way to measure the interaction between α-thrombin and the
TBAs nanoparticles, as the change can be visualized within a direct step and it is not cost nor
time consuming. This result confirmed that macromolecular aggregation processes can be studied
indistinguishably by these two types of nanoparticles, demonstrating that the gold coating maintains
the chemical and optical properties of gold itself.
2.4. DLS Study of the Complex Formation between α-Thrombin and NPs-TBAs
The study of the complex formation between the three types of NPs–TBAs and α-thrombin by
dynamic light scattering was carried out in phosphate buffer with additional K+ at 25 ˝C. Figure 4 and
Table 2 show the particle size distribution for the mixture of the different types of TBAs nanoparticles
with and without α-thrombin. Particle size analysis was performed after the addition of α-thrombin
into a mixture of TBA1 and TBA2 anchored to the three different types of nanoparticles (AuNPs,
SPIONs and AuSPIONs). In all three cases the average diameter of the nanoparticles immediately
increased by 25-, 21.5- and 7-fold (see Table 2). Even if a small polydispersity is observed in the initial
state of the mixture with AuSPION, we can clearly detect the formation of the α-thrombin-TBAs
network with a detection limit of 50 pmols of DNA No precipitation was observed at these complexes
concentration during the measurements. Similar results were observed for the SPIONs independently
of the linker used for the functionalization.
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Table 2. Size distribution (HD, nm) by DLS of TBAs nanoparticles in the absence and in the presence 
of α-thrombin. 
Nanoparticles Type Without α-Thrombin 
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With α-Thrombin 
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AuNPs 
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O6-MeG-TBA1 & TBA2 38 ± 5 56 ± 7 
SPIONs 
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Figure 4. Particle size distribution of NPs-TBAs at 25 ˝C recorded by DLS. The mixtures of TBA1
and TBA2 NPs (left) and O6´MeG-TBA1 and TBA2 NPs (right) are displayed in dashed blue, while
the same NP mixtures in the presence of α-thrombin are represented in orange. Each image is the
result of the combination of two DLS experiments with and without α-thrombin. The individual DLS
measurements are shown in Figure S4 (ESI). In all cases, the molar ratio of α-thrombin: TBAs was
0.5:1. From top to bottom: (a) AuNP, (b) SPIONs and (c) AuSPION.
Table 2. Size distribution (HD, nm) by DLS of TBAs nanoparticles in the absence and in the presence
of α-thrombin.
Nanoparticles Type Without α-ThrombinHD (nm)
With α-Thrombin
HD (nm)
AuNPs
TBA1 & TBA2 38 ˘ 5 947 ˘ 283
O6-MeG-TBA1 & TBA2 38 ˘ 5 56 ˘ 7
SPIONs
TBA1 & TBA2 36 ˘ 5 781 ˘ 185
O6-MeG-TBA1 & TBA2 39.5 ˘ 11 39.5 ˘ 11
AuSPIONs
TBA1 & TBA2 91 ˘ 25 633 ˘ 225
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In contrast, the interaction between equal concentrations of α-thrombin with the mixture of each
one of the three types of O6-MeG-TBA1 and TBA2 nanoparticles was inexistent or clearly smaller
(see Table 2). These observations indicate that α-thrombin was not able to form the network with
the same efficiency when the TBA1 was substituted by methylated TBA1, and thus the particle size
average remained similar. In these cases, the interaction between NPs–TBA2 and α-thrombin was not
identified. We presume that this may be due to the small variation in the size of the nanoparticles,
which is too low to be observed by DLS.
2.5. Magnetic Resonance Imaging
The study of the complex formation between α-thrombin and the TBA aptamers by magnetic
resonance imaging was already been described by Yigit et al. [41]. In our work we went a step
forward in the application of the MRI technique using gold-coated magnetic nanoparticles as contrast
agents, studying also the effect produced in the MRI contrast when TBA1 is substituted by a
methylated TBA1.
A 1:1 mixture of TBA1 or O6-MeG-TBA1 and TBA2 anchored to SPIONs or AuSPIONs was
prepared in phosphate-K+ buffer at 25 ˝C. Table 3 summarizes the formation of the molecular
network due to α-thrombin binding to the nanoparticles, monitored by the changes in brightness
of the T2-weighted MR images. A 2.4 µg Fe/mL concentration of the SPIONs resulted in a T2 of
50 ˘ 3 ms with a detection limit in the low picomolar range. After aggregation of the mixture by
adding α-thrombin, the magnetic relaxation properties changed, reducing the T2 relaxation time to
40 ˘ 3 ms. Even if the concentration of the AuSPIONs nanoparticles was required to be 1000 times
higher, due to the fact that the gold coating decreases the magnetic response, a similar reduction
in the T2 was observed. Again, the T2 values for the mixture containing methylG-TBA1 did not
decrease when α-thrombin was added, indicating that the network could not be formed. These
observations are in agreement with our previous results obtained by UV and DLS studies, and prove
that gold-coated magnetic NPs can be used for MRI detection of biomolecules.
Table 3. T2 relaxation times in the absence or presence of α-thrombin. SPIONs were measured at
1/1000 (2.4 µg Fe/mL) and the AuSPIONs 1/1 (2.4 mg Fe/mL). These results represent the average
of at least three independent measurements.
Nanoparticles Type Concentration of α-Thrombin
0 5 nM
SPIONs
TBA1 & TBA2 50 ˘ 3 ms 40 ˘ 3 ms
O6-MeG-TBA1 & TBA2 51 ˘ 4 ms 51 ˘ 5 ms
AuSPIONs.
TBA1 & TBA2 70 ˘ 1 ms 62 ˘ 1 ms
O6-MeG-TBA1 & TBA2 63 ˘ 2 ms 62 ˘ 1 ms
3. Experimental Section
3.1. Chemicals
Human α-thrombin was purchased from Heamatologic Technologies Inc (Cambridge, UK). All
reagents and dry solvents were from Sigma-Aldrich (Tres Cantos, Spain) or Fluka (Sigma-Aldrich
Quimica S.A, Alcobendas, Spain). Other chemicals from specific commercial source will be
specified as they are named. Standard phosphoramidites were purchased from commercial sources
(Applied Biosystems, Foster City, CA, USA). Oligonucleotide synthesis reagents were from ABI
(Foster City, CA, USA). Gold nanoparticles (10 nm) stabilized in aqueous solution of citrate were
purchased from Sigma-Aldrich. Low binding eppendorf tubes were used in the preparation of the
nanoparticles in order to avoid adsorption to the tube. The matrix for MALDI-TOF measurements
had 2’,4’,6’-Trihydroxyacetophenone (THAP, Sigma-Aldrich Tres Cantos, Spain) and ammonium
citrate (Fluka).
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3.2. Instrumentation
RP-HPLC was performed as described [52]. Oligonucleotide concentration and UV spectra
were measured on a JASCO V-650 instrument. Mass spectra were recorded on a MALDI Voyager
DE™ RP time of-flight (TOF) spectrometer (ABI, Foster City, CA, USA). Dynamic light scattering
(DLS) studies were performed on a DLS spectrometer (LS Instruments, Fribourg, Switzerland)
equipped with a He-Ne laser (Brookhaven Instruments Corporation, Holtsville, NY USA, 632.8 nm).
MRI measurements were performed on a Bruker Avance AV600 spectrometer (Bruker Biospin,
Rheinstetten, Germany) equipped with a 10 mm 1H micro-imaging probe and a variable-temperature
control unit. Acquisition and data processing were done using ParaVision v. 4.0 (Bruker BioSpin MRI,
Rheinstetten, Germany). TEM analysis was performed on a Transmission Electron Microscope (TEM)
LIBRAr 200FE (Carl Zeiss AG, Jena, Germany) with an electron beam source of 200 keV, a resolution
power of 0.24 nm and a magnification of 8ˆ–1,000,000ˆ.
3.3. Oligonucleotides Synthesis
The three oligonucleotide sequences (Table 1) were prepared on 200-nmol scale synthesis
using an ABI 3400 DNA Synthesizer (ABI, Foster City, CA, USA). The preparation of thiolated sequences
at the 5’-end implied the use of 5’-thiol modifier C6 S–S phosphoramidite (Link Technologies, Glasgow,
Scotland, UK). For strands containing O6-MeG, we used GDMF phosphoramidite. O6-MeG-TBA1 was
deprotected in ammonia solution, overnight at room temperature. The resulting products were desalted
on NAP-10 columns (Amersham Biosciences, Barcelona, Spain) and analyzed by reversed-phase
HPLC. All the products had the expected mass by MALDI-TOF. HO(CH2)6–S–S–(CH2)6–T15TBA1
[M] = 9617.1 (expected 9612.6), HO(CH2)6–S–S–(CH2)6–T15–O6–MeG–TBA1 [M] = 9621.4
(expected 9626.6), HO(CH2)6–S–S–(CH2)6–T5–TBA2 [M] = 10795.5 (expected 10797.9).
3.4. Synthesis of SPIONs
DMSA coated FexOy nanoparticles were obtained in good yield through thermal decomposition,
following the protocol reported by Salas et al. [55]. Resulting NPs show superparamagnetic properties
and are active in MR imaging. According with the synthetic methodology, the material is composed
by a mix of magnetite (Fe3O4) and maghemite (γ-Fe2O3) [60]. Due to that, the SPIONs are
labelled as FexOy.
3.5. Synthesis of Maleimide Linker
2-(2-Aminoethoxy)ethanol (2 mL, 18 mmol) was protected with (BOC)2O in THF, followed
by a standard workup. The resulting protected compound was left to react with maleimide
(2.1 g, 22.5 mmol) in THF, and a freshly solution of PPh3 (3.6 g, 13.5 mmol) followed by DIAD
(3.6 mL, 18 mmol) as described [58]. The product was precipitated in Et2O, filtered and purified
by flash chromatography (Hexane/AcOEt 5:2 to 1:1). Then, it was deprotected with trifluoroacetic
acid and purified to obtain a final yield of 89%. The resulting product had the same physical and
spectroscopical properties as the one described by Weber et al. [61]. See Supplementary Materials for
more detailed description of the synthesis and characterization of these products (see Figure S5).
3.6. Synthesis of Thiopyridinyl Linker (PDA*HCl)
The thiopyridinyl linker was obtained following reported protocols [59]. Briefly, to a solution of
aldrithiol (213 mg, 0.96 mmol) in MeOH, 2-mercaptoethylamine hydrochloride (109 mg, 0.96 mmol)
was added. After 1hr of stirring, the reaction was stopped by evaporation of the solvent and the
residue was washed with cold AcOEt three times. PDA*HCl was obtained in 51% yield (white solid).
1H-NMR (300 MHz, CD3OD) δ 8.57 (d, 1H, J = 5.0 Hz), 7.83 (t, 1H, J = 7.7 Hz), 7.69 (d, 1H, J = 8.0 Hz),
7.35 (dd, 1H, J = 7.5, 5.0 Hz), 3.18 (t, 2H, J = 6.1 Hz), 3.07 (t, 2H, J = 6.8 Hz).
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3.7. Functionalization of DMSA Coated FexOy Nanoparticles with Maleimide or PDA*HCl Linker
To 1 mL of SPIONs at 2.4 mg Fe/mL, the maleimide or PDA*HCl linker (50 µmol/g Fe),
1 equivalent of NaHCO3, 150 µmol of WSC(EDC)/g Fe and 75 µmol of NHS/g Fe were added. The
suspension was stirred at R.T. overnight. The resulting NPs were washed by iterative centrifugation
and redispersion in milliQ water for at least 3 times.
3.8. Synthesis of AuSPIONs
3.8.1. Synthesis of FexOy MNP as Seeds
First, 0.355 g of iron (III) acetylacetonate (1 mmol) were dissolved in phenyl ether (10 mL) with
oleylamine (1 mL, 2 mmol) and oleic acid (1 mL, 3 mmol) in inert (Ar) atmosphere and vigorous
stirring. Then, 1.29 g of 1,2-hexadecanediol (5 mmol) were added and the resulting mixture was
heated under reflux for 2 h at 210 ˝C. Finally, the resulting suspension was left to cool down to
R.T. [45]. The final solutions were used in the following steps without further purification.
3.8.2. Reduction of Au–Acetate (Coating)
First, 2.5 mL of the FexOy nanoparticles solution previously prepared (approximately
0.166 mmol FexOy) were diluted to a final volume of 7.5 mL in phenyl ether and mixed up with
Au(OOCCH3)3 (0.55 mmol, 0.208 g), oleic acid (0.375 mmol, 0.125 mL), oleylamine (1.5 mmol,
0.75 mL) and 1,2-hexadecanediol (3 mmol, 0.775 g), under Ar atmosphere and strong stirring. Then,
the temperature of the solution was increased following a ramp of 10 ˝C/min until reaching 190 ˝C,
and the suspension was refluxed for an extra 1.5 h. Then, AuSPIONs were precipitated with ethanol
and purified by centrifugation. The precipitate was washed twice and redispersed in a 1 M TMAOH
solution. Then, 0.04 g of trisodium citrate were carefully added adjusting the pH of the solution to 6.5.
Finally, the solution was sonicated for 30 min, and the nanoparticles were collected using a magnet
and redispersed in pure water [46,47].
3.9. Functionalization of the Different Type of Nanoparticles
3.9.1. Gold Nanoparticles (AuNPs)
First, 2–3 ODs of TBA1, -TBA2 and O6-MeG-TBA1 were reduced with 300 µL TEAAc 0.1 M and
TCEP¨HCl 34 µL (100 mM) at 55 ˝C overnight, to prevent the formation of disulfide bridges and
to break the already existing ones. Next, 1 OD of the deprotected oligonucleotides were diluted in
0.5 mL of MilliQ water and desalted (NAP-5 column). The resulting solution (1 mL) was mixed with
the AuNPs solution (1 mL) and left to conjugate overnight under agitation. Then, the solutions were
adjusted to 10 mM NaxPO4Hy (pH = 7.0). The resulting mixtures were allowed to equilibrate and
then they were brought to a concentration of 0.15 M sodium chloride stepwise and over a period
of 9 h. The solutions were treated in a sonicator for 10 s before every addition in order to keep
nanoparticles dispersed. Then, the suspensions were incubated overnight at room temperature. At
the end, the nanoparticles were purified by centrifugation at 13,200 rpm (16,100ˆ g) using a buffer
containing 0.15 M sodium chloride, 10 mM NaxPO4Hy (pH = 7) and NaN3 0.01%. The centrifugation
process was performed 4 times for 45 min at 15–20 ˝C. The TBAs-conjugated gold nanoparticles were
analyzed by UV–visible absorption. TBAs conjugated nanoparticles were stored at 4 ˝C and sonicated
during 5 min before use.
3.9.2. Superparamagnetic Iron Oxide Nanoparticles (SPION)
Aliquots of thiolated-aptamers (TBA1, TBA2 and O6-Me-TBA1) for a final concentration of
245 µM were mixed with 200 µL of 2.4 mg Fe/mL FexOy magnetic nanoparticles functionalized
with maleimido and 2-thiopyridinyl groups [57] and left overnight at R.T. The TBA-conjugated
nanoparticles were purified by iterative centrifugation-resuspension process. The centrifugation
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was repeated 3 times for 30 min at maximum speed at room temperature and with the addition
of small amounts of NaCl to enhance precipitation if required. The covalently immobilized TBA
was determined by quantification of the unbound TBA in the collected supernatants. The TBAs
conjugated nanoparticles were analyzed by UV–visible absorption and stored at 4 ˝C until further use.
3.9.3. Gold Superparamagnetic Iron Oxide Nanoparticles (AuSPION)
Equal volume of gold coated nanoparticles and thiolated DNA solution (1 OD) were mixed and
left to conjugate under agitation and at R.T. for 48 h. The resulting mixtures followed the same salt
aging process than AuNPs and the resulting suspension was centrifuged under the same conditions
used for the AuNPs, resuspended in MilliQ water to remove non-conjugated oligonucleotides,
and observed for any indication of aggregation. Finally, the conjugated oligonucleotides gold
coated superparamagnetic nanoparticles were analyzed by UV–visible absorption. The conjugated
nanoparticles were kept at 4 ˝C in MilliQ water until further use, due to precipitation when adding
salts to the solution.
3.10. Studies of α-Thrombin Interactions with TBA-Functionalized AuNPs and AuSPIONs by UV
The interactions between α-thrombin and TBA1, TBA2 and O6-MeG-TBA1 nanoparticles were
monitored by measuring changes in the UV spectrum (recorded from 650 to 400 nm) upon increasing
concentrations of the protein (125 nM up to 1 µM). A mixture of NP–TBA1 and NP–TBA2 were
diluted in buffer containing 10 mM phosphate pH 7 and 5 mM KCl to reach a concentration of
5 nM of nanoparticles in a volume of 500 µL. As conjugation was approximated to represent a coating
of 100 oligonucleotides per nanoparticle, the concentration of DNA in the sample was considered to
be around 500 nM. Each time, enough quantity (125 nM) of human α-thrombin was added. After a
quick manual mix, the UV spectra were recorded. The UV spectra of the mixture and increasing
concentrations of α-thrombin was recorded until reaching a final concentration of 1 µM, which
represents a 2:1 molar ratio between α-thrombin and DNA. This same experiment was repeated
using the modified NP–methyl TBA1 and NP–TBA2. All spectra were overlaid together to study
the displacement of the maximum peak from 520 nm in case of AuNPs and 545 nm for AuSPIONs to
higher wavelengths, due to the formation of a network of TBAs-α-thrombin complexes. Negative
controls have been carried on by using TBA1, TBA2 and O6-MeG-TBA1 along with increasing
concentrations of hAGT and scrambled DNA along with α-thrombin. The protocol used for these
studies was the same for AuNPs and for AuSPIONs.
3.11. Studies of α-Thrombin Interaction with TBAs Nanoparticles (AuNPS, SPIONs and AuSPIONs)
by DLS
Binding between α-thrombin and TBA1, TBA2 and O6-MeG-TBA1 nanoparticles was studied by
DLS measuring the average HD of the TBA-functionalized particles at R.T. The molecular network
originated from this binding was monitored by measuring the particles’ radius enlargement upon
increasing concentrations of the protein. One hundred microliters of a 5 nM mixture of NP–TBA1
and NP–TBA2 in buffer containing 10 mM phosphate (pH = 7) and 5 mM KCl were measured during
100 s using a 3D cross method with a scattering angle of 90˝ at 25 ˝C. The final concentration of
the TBAs in the samples was 500 nM. Enough quantity of human α-thrombin was added to reach
a 0.5:1 molar ratio between α-thrombin and DNA. After a quick manual mix, the radius length was
recorded. The same experiment was repeated using the modified NP–O6-MeG-TBA1 and NP–TBA2.
The particle radius was measured by adjusting the first cumulant parameter. The relative intensity
of the different particle complexes was measured by computer fitting the contin parameter. All the
experiments were performed in triplicates. The procedure of the DLS measurements was the same
for AuNPs, SPIONs and AuSPIONs.
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3.12. Studies of α-Thrombin Interaction with TBAs Nanoparticles (SPIONs and AuSPIONs) by MRI
NPs–TBA1 (or NPs–O6-MeG-TBA1) and NPs-TBA2 were mixed in 1:1 ratio. Then, the mixture
was diluted in 100 mM sodium chloride, 25 mM potassium chloride and 25 mM tris-HCl at pH = 7.4.
The final concentration of nanoparticles was 2.4 µg Fe/mL in the case of the SPIONs and 2.4 mg/mL
for the AuSPIONs. Then, the samples were incubated with different concentrations (0, 5, 10 and
20 nM) of α-thrombin. One hundred microliters of the mixed sample were loaded into a microcapillar
and T2 experiments were recorded. The magnetic field strength was 14 T. This corresponds to a 1 H
resonance frequency of 600.1 MHz. The images of the solutions were acquired at R.T. We used the
following parameters for the acquisition of data: number of slices: 1; MSME (Multi Slice Multi Echo)
acquisition; thickness: 1.50 mm; echo time: 4.5 ms; repetition time: 1500 ms; number of echoes: 10;
FOV: 0.8 mm. We performed two scans. This corresponds to a total acquisition time of 12 min. T2
values were extracted using a non-linear multi-parametric fitting y = A + Be ´ t/T2 of the intensity
decays. All measurements were performed by triplicate of four independent experiments. The MRI
measurements of the AuSPION were performed following the same protocol as the one used for the
SPION. Acquisition and data processing were performed with ParaVision v. 4.0 (Bruker BioSpin MRI,
Rheinstetten, Germany).
4. Conclusions
We have obtained in high yield and purity gold-coated magnetic nanoparticles. Their
functionalization with oligonucleotides is comparable with the one obtained for the gold
nanoparticles. Our results prove the capacity of AuSPIONs to detect a protein by three diverse
techniques. AuSPIONs were suitable for UV experiments with the same performance as AuNP,
without major changes in the execution nor in the detection limit. AuSPIONs showed similar
behavior in DLS measurements to AuNPs and SPIONs, resulting in very similar plots of size
distribution. Finally, AuSPION were useful for MRI experiments, even if they showed a shielding
of the magnetic resonance due to the gold coating and required higher concentrations to reach the
same signal as SPIONs.
Furthermore, this work proves that AuSPION, as well as AuNPs and SPIONs, can discriminate
a native TBA from a methylated one in the analysis of the complex formation between TBAs
and α-thrombin by biophysical methods. As O6-methylguanine is the substrate for DNA repair
enzymes, critical for chemotherapy resistance, this method can also be used to monitor the activity
of these DNA repair proteins. Different detection methods for the evaluation of the repair activity
of one of them, alkylguanine–DNA-transferase (hAGT) [62] have been previously described [52,53].
These methods are also based on the conformational change of TBA upon methylation of a single
guanine. Its repair restores the G-quadruplex and its recognition by α-thrombin. We envisage
that AuSPIONs are useful for the development of a new methodology to detect hAGT activity in
a straightforward manner. Work in this direction is currently ongoing in our laboratory. We believe
that the multidisciplinary detection capacity of AuSPIONs can be evolved to design more complex
biosensors for biomedical applications as well as for drug delivery and in vivo imaging.
Supplementary Materials: Supplementary Materials are available online at www.mdpi.com/1422-0067/
16/11/26046/s1.
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Abbreviations
AuNPs: gold nanoparticles, AuSPIONs: gold-coated superparamagnetic iron oxide nanoparticles,
DLS: dynamic light scattering, DMF: dimethylformamidino group, DMSA: dimercaptosuccinic
acid, DTT: dithiothreitol, FexOy: iron oxide, hAGT: human O6-alkylguanine–DNA alkyltransferase,
HD: Hydrodynamic diameter, HPLC: high performance liquid chromatography, LSPR: localized
surface plasmon resonance, MRI: magnetic resonance imaging, NHS: N-hydroxysuccinimide, NPs:
nanoparticles, O6-MeG: O6-methylguanine, O6-MeG-TBA1: O6-methylguanine α-thrombin-binding
aptamer, R.T. room temperature, SPIONs: superparamagnetic iron oxide nanoparticles, T2: spin-spin
relaxation time, TBA: α-thrombin-binding aptamer, TCEP¨HCl: tris(2-carboxyethyl)phosphine
hydrochloride, TEAAc: triethylammonium acetate, TEM: transmission electron microscopy,
TMAOH: tetramethylammonium hydroxide, Tris: Tris(hydroxymethyl) aminomethane, WSC water
soluble carbodiimide (also abbreviated as EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
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